DOTmed users are familiar with the outstanding reputation of women's health company Hologic, makers of technologies including digital mammography and bone densitometry. The recent release of their latest earnings report caused quite a buzz including a segment on CNBC. And with good reason: Hologic reported record revenues exceeding $370 million for the quarter ending December 29, 2007. Revenues, adjusted earnings and backlog all increased to record highs.

Highlights of the quarter include:
-Record revenues of $371.4 million.
-Merger with Cytyc Corporation on October 22, 2007 contributes $158 million of revenue (for 10 of 13 weeks).
-Record 384 Selenia full field digital mammography systems installed and recognized as revenue.
-Record backlog of $244.5 million for historical businesses (mammography/breast care/skeletal health).
-Issued $1.725 billion of convertible senior notes (at 2% interest).
-Term loan balance reduced to $295 million at December 29, 2007.
-Reported net loss of $358.6 million due primarily to non-cash charges related to the Cytyc merger.
-Hologic was added to the Nasdaq-100 index® on December 24, 2007.

First quarter fiscal 2008 revenues totaled $371.4 million, a 128% increase when compared to revenues of $163.2 million in the first quarter of fiscal 2007. The increase was primarily attributable to the inclusion of Cytyc revenues for the period from October 22, 2007 (the merger date) to December 29, 2007, which approximated $158 million. For the first quarter of fiscal 2008, Hologic reported a net loss of $358.6 million, or $3.31 per diluted share, compared with net income of $16.1 million, or $0.30 per diluted share, in the first quarter of fiscal 2007. Included in the first quarter of fiscal 2008 results were charges relating to the Cytyc merger of $370.0 million attributable to acquired in-process research and development costs, $41.5 million attributable to the increase in cost of revenues relating to the write-up of inventory to fair market value, and $20.4 million attributable to the amortization of intangibles.

"We are pleased with our fiscal first quarter results which were slightly above expectations and provide a solid foundation for achieving our goals this fiscal year," said Jack Cumming, Chief Executive Officer. "The demand for our products remains strong and we look forward to the full contribution from our enhanced sales capabilities and to fully leveraging the synergies of our recent acquisitions as we progress through the year."

In connection with its transformational merger with Cytyc in early fiscal 2008, the Company added two significant new operating segments and combined a number of previous operating segments to better align the new resources of the combined company.

The Company now has four reporting segments: Breast Health (formerly Mammography/Breast Care), Diagnostics, GYN Surgical and Skeletal Health. The Diagnostics and GYN Surgical reporting segments were previously part of Cytyc. The AEG and MammoSite (formerly a part of Cytyc) operations are now included in Breast Health, and the osteoporosis assessment, mini C-arm and MRI products are included in Skeletal Health.

Read all the numbers at
http://www.hologic.com/ir/fr013108.htm